Product Information
RIZATRIPTAN 5 MG ODT is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.5720 per EA under NDC 68462046706. Its NADAC has been published 606 times since Nov 28, 2013.
FDA first approved this application on Jul 1, 2013.
Strength
5 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462046706
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
6/18/2025
Active Ingredients
RIZATRIPTAN BENZOATEApproval Type
Generic (ANDA)
FDA Application
ANDA201914FDA Approved
7/1/2013
On Market Since
7/1/2013
Pharmacological Classes
Price Statistics
The NADAC for RIZATRIPTAN 5 MG ODT has been published 606 times since Nov 28, 2013, and over the history we have for it it has declined 95.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5720 per EA |
|---|---|
| All-time high | $12.3140 (Dec 11, 2013) |
| All-time low | $0.4078 (Jul 17, 2024) |
| Median price | $1.0502 |
| Average price | $1.1136 |
| Largest weekly change | -70.8% (Jan 22, 2014) |
| Weeks tracked | 606 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-14.6%
5Y
-41.9%
All
-95.4%
Last surveyed Jul 2, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIZATRIPTAN 5 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 5 MG ODT, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.5720 per EA (NDC 68462046706), effective Jul 2, 2025.
How has the price of RIZATRIPTAN 5 MG ODT changed over time?
Over the history we have for it, the NADAC for RIZATRIPTAN 5 MG ODT has declined 95.4%. It has been tracked across 606 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 5 MG ODT?
Since Nov 28, 2013, the NADAC for RIZATRIPTAN 5 MG ODT has ranged from a low of $0.4078 (Jul 17, 2024) to a high of $12.3140 (Dec 11, 2013), with a median of $1.0502 per EA.
Are there cheaper alternatives to RIZATRIPTAN 5 MG ODT?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIZATRIPTAN 5 MG ODT, is $0.5150 per EA — about 10% below RIZATRIPTAN 5 MG ODT.
Who manufactures RIZATRIPTAN 5 MG ODT?
RIZATRIPTAN 5 MG ODT (NDC 68462046706) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.